Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial-Reference-Cited by-同舟云学术

Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial

Published:2016-01 Issue:1 Volume:94 Page:85-92
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Blanchard Pierre^ORCID,Faivre Laura,Lesaunier François,Salem Naji,Mesgouez-Nebout Nathalie,Deniau-Alexandre Elisabeth,Rolland Frédéric,Ferrero Jean-Marc,Houédé Nadine,Mourey Loïc,Théodore Christine,Krakowski Ivan,Berdah Jean-François,Baciuchka Marjorie,Laguerre Brigitte,Davin Jean-Louis,Habibian Muriel,Culine Stéphane,Laplanche Agnès,Fizazi Karim

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer;Blute;J Urol,2000

2. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update;Partin;JAMA,1997

3. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer;Roach;Int J Radiat Oncol Biol Phys,1994

4. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: The essential importance of percentage of positive cores;Briganti;Eur Urol,2012

5. Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection;Abdollah;Radiother Oncol,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unfavorable Intermediate- and High-Risk Prostate Cancer Treated With Predominantly Brachytherapy Alone With Long-Term Follow-Up;Applied Radiation Oncology;2023-12-01

2. Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis;International Journal of Radiation Oncology*Biology*Physics;2023-10

3. The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis;Clinical and Translational Radiation Oncology;2022-09

4. Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma;Biomedicines;2022-08-17

5. Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-01-27